The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess long-term effects of CTP-543 on treating hair loss in adult patients with chronic, moderate to severe alopecia areata.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
1,000
Twice daily dosing
Number of Participants with Adverse Events as a Measure of Safety
Time frame: 332 weeks
Effect of CTP-543 on treating hair loss as measured by the Severity of Alopecia Tool (SALT)
Time frame: 332 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Total Skin and Beauty Dermatology Center
Birmingham, Alabama, United States
Alliance Dermatology & MOHS Center
Phoenix, Arizona, United States
Center for Dermatology and Plastic Surgery/CCT Research
Scottsdale, Arizona, United States
Johnson Dermatology
Fort Smith, Arkansas, United States
Northwest Arkansas Clinical Trials Center, PLLC
Rogers, Arkansas, United States
Kern Research Inc.
Bakersfield, California, United States
Hope Clinical Research
Canoga Park, California, United States
California Dermatology & Clinical Research Institute
Encinitas, California, United States
University of California, Irvine
Irvine, California, United States
Dermatology Research Associates
Los Angeles, California, United States
...and 81 more locations